Organization

Founding Members


Gérard Saillant
Professor of Orthopedics and Traumatological Surgery
Chairman of the ICM

Former professor of orthopedic surgery, Dean of the Faculty of Medicine, Head of the Orthopedic, traumatologic and reparatory surgery at the Pitié-Salpêtrière Hospital since 1993, Gérard Saillant is one of the foremost specialists in sports medicine and spinal surgery.


Jean Todt
President of FIA
Vice-Chairman of the ICM

“During my entire career I have had the opportunity to meet extraordinary people, among whom professor Gérard Saillant. Together we felt the need to do something to help others. This is why we have brought together personalities from various horizons who share the desire to commit personally to creating a research centre focusing on the brain and the spinal cord where the potential for improvement is immense. We are aware of the scope of the project and the obstacles ahead … but also and especially of the formidable hope it represents. With our ‘dream team’ and the support of all those who accept to help us, the ICM will quickly become a reality.”


Yves Agid
Professor of Neurology and Neurosciences

Professor and hospital practitioner, former Head of the department of neurology at the Pitié-Salpêtrière Hospital, Yves Agid is also a Doctor of Science, Director of the Federative Institute of Neuroscience at the Pitié-Salpêtrière University Hospital. As Laureate of the INSERM Grand Prix in 2001, he received a lifetime achievement award in neuroscience. As clinician his activities focus primarily on movement disorders (Parkinson’s disease, dystonia, tremours …), neuropsychology (intellectual and psychological disorders of all kinds) and neurogenetics (hereditary diseases of the nervous system).


Luc Besson
Film Director

“Neurological diseases strike everyone regardless of age, race and social background. This is why I wanted my support to draw public attention to the necessity of opening a centre of research and care such as this one.”


Louis Camilleri
President of Altria

“I have been particularly impressed by the generosity and motivation of the initiators. But equally by the considerable number of pathologies that the ICM focuses on … So if my contribution however modest can help this institution take form and change the life of those who are struck by these diseases of the brain and the spinal cord, it will not have been in vain.”


Jean Glavany
Former Minister
Deputy of Hautes-Pyrénées

“The ICM project is a generous idea carried by a group of friends wanting to make it come true. But this human adventure will only succeed if we manage to bring thousands of people to help it along. I try to bring my modest experience to the team by forging links and potential institutional partnerships with ministries, the regional authority, the city of Paris, the university, the public hospitals of Paris, the Caisse des Dépôts and major research organisations.”


Maurice Lévy
CEO of Publicis

“The sheer number and complexity of diseases involving the brain, the spinal cord and the nervous system are on the rise. A great initiative was required to bring together scientists around a grand design. ICM has achieved this and it is probably the most significant initiative in medical research in the past 50 years involving people of exceptional talent, devotion and quality.”


Olivier Lyon-Caen
Professor of Neurology, Director of the department for Nervous System Diseases at the La Pitié-Salpêtrière’s Hospital

Professor at the Faculty of Medicine (Paris VI), MD, neurologist, Head of department at the Pitié-Salpêtrière Hospital, Olivier Lyon-Caen is also member of the INSERM Unit 360. Professor Lyon-Caen is particularly involved in myelin-related disorders (multiple sclerosis), metabolic disorders and neuro-immunology.


Jean-Pierre Martel
Lawyer

“By nature a lawyer is somebody who cares about others, putting his energy and knowledge at the service of the causes he seeks to further. At the ICM I have been fortunate enough to meet exceptional people committed to a common project, a great cause. So yes, I’m happy to get involved personally and bring the support and know-how of my law firm. This will be my contribution, of which I am proud, to the realization of the ICM and its success.”


Max Mosley
Former president of the FIA

“The FIA Foundation has chosen to support the ICM, as the most serious traumatic conditions linked to road accidents are unfortunately brain and spinal cord damage. This type of accident remains too frequent. The research conducted by the ICM will help to develop efficient treatments for this kind of lesions. Thus our support is conform to the goals set within our international campaign for road safety.”


Lindsay Owen-Jones
President of L’Oréal
Honorary chairman of the Friends of the ICM Comittee

“The ICM is a great project carried by a team of exceptional scientists which I am proud to support. My career has been a series of economic and sportive challenges. A full life which today gives me reason to turn towards others and commit to those who are concerned with this major public health issue.”

Photo_Fondation_David-de-RothschildDavid de Rotschild
President of Banque Rothschild et Cie.
Co-chairman of the Friends of the ICM Comittee

« “Les multiples défis que lance à la science l’allongement de la vie, avec ses conséquences sur le développement des maladies du cerveau, méritent que nous
fassions un effort de recherche conséquent. En outre, on peut ressentir une certaine fierté nationale à voir ce beau projet qu’est l’ICM prendre corps à Paris, rassembler des médecins et des chercheurs éminents venus du monde entier, et ce non seulement sur fonds publics mais aussi grâce au soutien de donateurs. »


Michael Schumacher
Formula 1 Racing Driver

“At the beginning, my interest in the ICM was motivated by strictly personal reasons, and in particular the strong relationship with Jean Todt and Gérard Saillant. I was certain that I could trust them completely. This was and still is very important to me. The idea of creating a research centre is fascinating from many points of view: because it will help the understanding of how the brain works and to find solutions and cures. Those privileged by life have the duty to help those who are less fortunate and especially those who suffer. Thus I believe that my duty is to help them accomplish this project. My role in the ICM was initially to help financially. Today I would like to put my notoriety at the service of the ICM in order to publicize the project, in particular by approaching companies which may join our cause.”


Serge Weinberg
President of Weinberg Capital Partners
The ICM’s Treasurer

“Brain diseases concern a growing number of people. This is a major concern for the future of our societies. In helping this exemplary project based on a close public-private partnership, participating in a team involving scientists, entrepreneurs, personalities, by financing the ICM I have the feeling of doing something useful.”

Board of Directors

Chairman
Gérard Saillant


Vice-Chairman
Jean Todt


Founding Members
• Serge Weinberg
• Jean Glavany
• Jean-Pierre Martel
• Gérard Saillant
• Jean Todt


College of Experts
• Pierre Corvol, Collège de France
• Alain Prochiantz, École Normale Supérieure


• Bernard Bioulac, représentant du Centre National de la Recherche Scientifique (CNRS)
• Hervé Douchin, représentant de l’Institut National de la Santé et de la Recherche Médicale (INSERM)
• Bruno Riou, représentant de l’Université Pierre et Marie Curie (UPMC)
• Jean-françois Sauvat, représentant de l’Assistance Publique-Hôpitaux de Paris (APHP)


Friends of the Foundation
• Maurice Lévy
• David de Rothschild
• Lindsay Owen-Jones


Governement Representative
• Philippe Ritter


Honorary member
• Lily Safra

International Scientific Advisory Board

Pr. Peter Brown
ION, University College of London, UK

Pr. Ray Dolan
Cognisciences
University College of London, UK

Pr. Magdalena Götz
Münich Center For Neurosciences, Münich, Germany

Pr. Steve Hauser
UCSF School Med, San Fransisco, USA

Pr. Heidi Johansen-Berg
FMRIB, Univ Oxford, UK

Pr. Dimitri Kullman
Neurophysiology
University College of London, UK

Pr. Bertram Müller Myhsok
Cell biology
Max-Planck Institute, Münich, Germany

Pr. Hideyuki Okano
Nneurobiology
Keio University, Japan

Pr. William D. Richardson
Neurobiology
University College of London, UK

Pr. Peter St-George-Hyslop
Tanz Center for Neurodegenerative Diseases, University of Toronto, Ontario, Canada

Pr. Michael Shelanski
Neuropathology
Columbia University, New York, USA

Pr. Martin E. Schwab
Brain Research Institute, University & ETH Zürich, Switzerland

Pr. Gabor Tamas
University of Szeged, Hungary

Pr. Patrick Vuilleumier
Neuroscience Center, University Hospital, Geneva, Switzerland

Pr. Hartmut Wekerle
Max Plank Institute für Neurobiologie, Münich, Germany

Pr. Huda Y.Zoghbi, MD
Baylor College of Medicine, Houston, USA

Friends of the ICM Comittee


Lindsay Owen-Jones
President of L’Oréal Group
Honorary Chairman



David de Rothschild
Director General of Rothschild & Cie
Honorary Chairman



Jean Todt
President of FIA
Co-Chairman of the Comitee



Maurice Lévy
CEO of Publicis
Co-Chairman


Cédric de Bailliencourt
Financial Director of Groupe Bolloré

Jean Bousquet
President of Cacharel

Sylvain Hefes
Adviser NM Rothschild & Sons,
Ambassador of Friends of the ICM Comittee in Britain

François Henrot
Managing Partner, Rothschild & Cie

Jean-Philippe Hottinguer
Founder and Partner of Jean-Philippe Hottinguer & Cie

Leticia Poniatowski

Gérard Saillant
President and Founding Member of the ICM

Christian Schmidt de la Brélie
Director General of KLESIA Group

François Thomé
Lawyer

Isabelle Weill
Chairman of the RMC/BFM

Serge Weinberg
Treasurer and Founding Member of the ICM

Alain Wicker
Vice Chairman of the supervisory board of Française des Placements

Ambassadors


Michelle Yeoh
ICM Ambassador



Jean Reno
ICM Ambassador


Association “Friends of the Foundation”

Lily Safra
Chairman of the Edmond J.Safra Philanthropic Foundation
Honorary Chairman


Maurice Lévy
CEO of Publicis
Founding Member of the ICM

Olivier Lyon-Caen
Professor of Neurology, Director of the department
for Nervous System Diseases at the CHU Pitié-Salpêtrière

Founding Member of the ICM

Jean-Pierre Martel
Lawyer
Founding Member of the ICM

Serge Weinberg
President of Weinberg Capital Partners
Treasurer and Founding Member of the ICM

Organisation and financing of the ICM

Governance designed for effiency and flexibility
The ICM chose a governance structure that is built on a strong partnership between the public and private sectors, as reflected in the membership of its board of directors and management committees. They ensure that the ICM’s structure and resources are matched to its scientific goals. By implementing controls to ensure efficient management and regularly assessing the progress and performance of teams, its management team guarantees continued excellence. ICM adheres to a policy of full transparency with respect to its partners and publicly discloses information about its responsibilities and results in its annual report.

Making work easier for researchers
In leading, coordinating and managing this very high-level research work, the ICM undertakes to respect the creativity of its teams and facilitate their core purpose:research. Its administrative functions are designed to serve scientists. The ICM allows its researchers to focus fully on their work, by releasing them as completely as possible from the administrative, logistic and technical constraints that typically hinder their activity. The design of its organizational structure aims to give investigators freedom and fl exibility along with clearly defi ned research objectives. These optimal working conditions help break down barriers between teams and promote scientific synergy.

A brand new model
For its investments as well as its daytoday operation, the ICM, a foundation of public benefit*, has the support of its public institutional partners: the Ile-de-France region, the city of Paris, the public financing agency Caisse des Dépôts, the public health agency Assistance Publique-Hôpitaux de Paris, research institutes Inserm and CNRS and Université Pierre et Marie Curie.


The best of both worlds
From the public sector, ICM has statefunded researchers chosen through a stringent selection process. Its private funds make the Institute stronger and more flexible and allow it to react quickly.
Sponsorships and donations are crucial in order to:

  • independently finance teams or researchers recruited from around the world based on criteria of excellence;
  • implement innovative research programs;
  • create junior and senior chairs;
  • invest in cutting-edge equipment.

Support the ICM
The support of private partners and the generosity of individuals, whether through scientific partnerships, financial sponsorship or donations of equipment or skills, are vital. The decision to support the ICM is a concrete step toward ensuring the present and future well-being of millions of people around the world. To help researchers progress more rapidly and give patients tangible reasons for hope, the ICM needs support from each one of us.
* Decree of September 13, 2006.
Alongside public and private partners, our Founding Members, Honorary Committee members and International Scientific Advisory Board have all chosen to pool their talents and invest in the success of the Institute.

The team

ICM, Institut du Cerveau et de la Moelle épinière
Hôpital Pitié Salpêtrière
47 / 83, bd de l’hôpital
75013 PARIS
France
 
Tel : +33 (0)1 57 27 40 00
Fax : +33 (0)1 57 27 40 27
contact@icm-institute.org

Chairman: Professor Gérard Saillant
General Manager: Professor Alexis Brice
Administration Director: Anne Bellod
Communication and fundraising Director : Jean-Louis Da Costa
Head of Research & Technology Development: Alexis Génin
Director of IT systems: Dominique Bayle
Director of equipment and logistics: Didier Petiteville
Administration & finance manager : Aude Lemoine
Human resources manager : Cécile Proust
Scientific Animation: Professor Yves Agid

EquipeAdministrative2013-500